Fennec Pharmaceuticals is trading at $10.08 (+5.11%) today as the stock benefits from a broader risk-on tape and positive sentiment across the biotech sector.
- Major indices including the S&P 500, Nasdaq, and Dow are all trading sharply higher, providing a strong tailwind for equities.
- There are no company-specific announcements or fresh catalysts driving the move, suggesting the gain is primarily tied to overall market momentum.